Conference Coverage
Conference Coverage
Duodenal mucosal resurfacing has metabolic effects in type 2 diabetes
BOSTON – Improvements in HbA1c and NASH biomarker favored the procedure over sham procedure in first-ever randomized, double-blind...
Conference Coverage
High doses of FXR agonist tropifexor reduce hepatic fat, serum ALT in patients with NASH
BOSTON – Mild pruritus, minor decreases in LDL cholesterol are notable adverse effects of treatment, similar to others in class.
Conference Coverage
Fenofibrate fights increased triglycerides in NASH
BOSTON – Patients with advanced fibrosis caused by NASH had limited increase in triglycerides after treatment with varying doses of fenofibrate....
Conference Coverage
Glecaprevir/pibrentasvir highly effective in HCV genotype 3, among others
BOSTON – Pangenotypic regimen may further progress toward elimination of hepatitis C, investigators say.
Conference Coverage
DUR-928 shows promise for alcoholic hepatitis
BOSTON – Among 15 patients with severe alcoholic hepatitis, 87% responded to treatment (Lille score less than 0.45).
Conference Coverage
HDV combo therapy reduces viral loads
BOSTON – Interim results of the open-label LIFT trial show positive results after 6 months of therapy.
Conference Coverage
New antibody cuts the fat in NAFLD
BOSTON – In a phase 1b trial, treatment with tolerable doses of the bispecific antibody reduced hepatic fat fraction by a mean of 38%.
Latest News
Bariatric surgery shows metabolic benefits in lower-BMI patients
LAS VEGAS – Data from 45,000 patients showed that those who had a BMI below 35 kg/m2 benefited as much as those with higher BMIs.
Conference Coverage
Over-the-scope hemoclip prevails for upper GI bleeding
SAN ANTONIO – One audience member leapt to his feet to declare: “This is the study we’ve all been waiting for.”
Conference Coverage
Topical budesonide effective for eosinophilic esophagitis in pivotal trial
SAN ANTONIO – First U.S. phase 3 trial for eosinophilic esophagitis hits all endpoints.